Related references
Note: Only part of the references are listed.Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators
Menghan Niu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)
Impairments of glutamatergic synaptic transmission in Alzheimer's disease
Benedikt Zott et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2023)
Role of Metal Cations of Copper, Iron, and Aluminum and Multifunctional Ligands in Alzheimer's Disease: Experimental and Computational Insights
Nicolas Puentes-Diaz et al.
ACS OMEGA (2023)
Discovery of novel tryptamine derivatives as GluN2B subunit-containing NMDA receptor antagonists via pharmacophore-merging strategy with orally available therapeutic effect of cerebral ischemia
Jishun Quan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics
Vinod Ugale et al.
MOLECULAR DIVERSITY (2023)
Quantitative analysis of NMDA receptor subunits proteins in mouse brain
Yasuhiro Suzuki et al.
NEUROCHEMISTRY INTERNATIONAL (2023)
Pharmacological Potential of 3-Benzazepines in NMDAR-Linked Pathophysiological Processes
Nadine Ritter et al.
BIOMEDICINES (2023)
Black-Box Warnings of Antiseizure Medications: What is Inside the Box?
Abdul Wahab et al.
PHARMACEUTICAL MEDICINE (2023)
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson et al.
NEUROPSYCHOPHARMACOLOGY (2023)
Structural insights into NMDA receptor pharmacology
Changping Zhou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2023)
Discovery of Pyrazolo [1,5-a] pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity
Fumie Sakurai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias et al.
LIFE-BASEL (2022)
Aberrant maturation and connectivity of prefrontal cortex in schizophrenia-contribution of NMDA receptor development and hypofunction
Wen-Jun Gao et al.
MOLECULAR PSYCHIATRY (2022)
Structural insights into binding of therapeutic channel blockers in NMDA receptors
Tsung-Han Chou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2022)
Association of Iatrogenic Infarcts With Clinical and Cognitive Outcomes in the Evaluating Neuroprotection in Aneurysm Coiling Therapy Trial
Aravind Ganesh et al.
NEUROLOGY (2022)
The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
Shinhui Lee et al.
ANTIOXIDANTS (2022)
GluN2A-Selective NMDA Receptor Antagonists: Mimicking the U-Shaped Bioactive Conformation of TCN-201 by a [2.2]Paracyclophane System
Ruben Steigerwald et al.
CHEMMEDCHEM (2022)
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
Celia Seillier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Targeting NMDA Receptor Complex in Management of Epilepsy
Shravan Sivakumar et al.
PHARMACEUTICALS (2022)
Modulation of NMDA Receptors by G-protein-coupled receptors: Role in Synaptic Transmission, Plasticity and Beyond
Stefano Lutzu et al.
NEUROSCIENCE (2021)
NMDA receptors in axons: there's no coincidence
Hovy Ho-Wai Wong et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
Non-ionotropic NMDA receptor signaling gates bidirectional structural plasticity of dendritic spines
Ivar S. Stein et al.
CELL REPORTS (2021)
N-methyl-D-aspartate receptor function in neuronal and synaptic development and signaling
Jessica Pagano et al.
CURRENT OPINION IN PHARMACOLOGY (2021)
Glutamate receptors in brain development
Daniel Lawer Egbenya et al.
CHILDS NERVOUS SYSTEM (2021)
The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Esketamine: A Novel Option for Treatment-Resistant Depression
Kevin M. Bozymski et al.
ANNALS OF PHARMACOTHERAPY (2020)
Distinct Laminar Requirements for NMDA Receptors in Experience-Dependent Visual Cortical Plasticity
Ming-fai Fong et al.
CEREBRAL CORTEX (2020)
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity
Luca Franchini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Marta Vieira et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons
Chrysia M. Pegasiou et al.
CEREBRAL CORTEX (2020)
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
Molly C. Kalmoe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
Julia Companys-Alemany et al.
PHARMACEUTICS (2020)
A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
Wenwu Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Tetsuro Kikuchi
BIOMOLECULES (2020)
Ubiquitination and functional modification of GluN2B subunit-containing NMDA receptors by Cbl-b in the spinal cord dorsal horn
Zi-Yang Zhang et al.
SCIENCE SIGNALING (2020)
The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models
Samuel Ohiomokhare et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Alpha-synuclein is involved in manganese-induced spatial memory and synaptic plasticity impairments via TrkB/Akt/Fyn-mediated phosphorylation of NMDA receptors
Zhuo Ma et al.
CELL DEATH & DISEASE (2020)
Novel NMDA-receptor antagonists ameliorate vanadium neurotoxicity
A. D. Ladagu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Tissue-Type Plasminogen Activator Controlled Corticogenesis Through a Mechanism Dependent of NMDA Receptors Expressed on Radial Glial Cells
Nolwenn Pasquet et al.
CEREBRAL CORTEX (2019)
Alteration in NMDA Receptor Mediated Glutamatergic Neurotransmission in the Hippocampus During Senescence
Ashok Kumar et al.
NEUROCHEMICAL RESEARCH (2019)
Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes
Yingfang He et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
Role of adult-born granule cells in the hippocampal functions: Focus on the GluN2B-containing NMDA receptors
Julie Doan et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
An update on NMDA antagonists in depression
Bartlomiej Pochwat et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats
Robert Becker et al.
PSYCHOPHARMACOLOGY (2019)
An autism-associated mutation in GluN2B prevents NMDA receptor trafficking and interferes with dendrite growth
Michael P. Sceniak et al.
JOURNAL OF CELL SCIENCE (2019)
NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy
Md Tanvir Kabir et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature
Jasper Kamp et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Assessment and manifestation of central sensitisation across different chronic pain conditions
L. Arendt-Nielsen et al.
EUROPEAN JOURNAL OF PAIN (2018)
The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter
Yongjun Sun et al.
MOLECULAR NEUROBIOLOGY (2018)
The role of memantine in the treatment of major depressive disorder: Clinical efficacy and mechanisms of action
Meysam Amidfar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
The differences between GluN2A and GluN2B signaling in the brain
Yongjun Sun et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Mechanisms of ketamine action as an antidepressant
P. Zanos et al.
MOLECULAR PSYCHIATRY (2018)
Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7-NMDA Receptor Antagonists
Olga Karoutzou et al.
MOLECULES (2018)
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Glutamatergic Modulators in Depression
Ioline D. Henter et al.
HARVARD REVIEW OF PSYCHIATRY (2018)
Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
Marta Gordillo-Salas et al.
TRANSLATIONAL PSYCHIATRY (2018)
Structure, function, and allosteric modulation of NMDA receptors
Kasper B. Hansen et al.
JOURNAL OF GENERAL PHYSIOLOGY (2018)
Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study
M. Amidfar et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Systematic variation of the benzenesulfonamide part of the GluN2A selective NMDA receptor antagonist TCN-201
Sebastian L. Mueller et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat
Jonathan D. Raybuck et al.
JOURNAL OF NEUROSCIENCE (2017)
Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats
Bartlomiej Pochwat et al.
NEUROPHARMACOLOGY (2017)
Involvement of GluN2B subunit containing N-methyl-D-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD)
Gerhard Rammes et al.
NEUROPHARMACOLOGY (2017)
Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits
Genevieve E. Lind et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ION CHANNELS Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation
Wei Lu et al.
SCIENCE (2017)
The Role of NMDA Receptors in Neural Stem Cell Proliferation and Differentiation
Adri Chakraborty et al.
STEM CELLS AND DEVELOPMENT (2017)
Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
Lulu Yao et al.
NEURAL PLASTICITY (2017)
Identifying the Role of GluN2A in Cerebral Ischemia
Yongjun Sun et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins
Jesus Avila et al.
FRONTIERS IN NEUROSCIENCE (2017)
Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
Douglas Bledsoe et al.
FRONTIERS IN PHARMACOLOGY (2017)
A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine
Hongqiu Guo et al.
SCIENTIFIC REPORTS (2017)
Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain
Meysam Amidfar et al.
BRAIN RESEARCH BULLETIN (2017)
Investigation of antidepressant-like and anxiolytic-like actions and cognitive and motor side effects of four N-methyl-D-aspartate receptor antagonists in mice
Louise K. Refsgaard et al.
BEHAVIOURAL PHARMACOLOGY (2017)
GluN1 and GluN2A NMDA Receptor Subunits Increase in the Hippocampus during Memory Consolidation in the Rat
Magali C. Cercato et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2017)
Youthful Brains in Older Adults: Preserved Neuroanatomy in the Default Mode and Salience Networks Contributes to Youthful Memory in Superaging
Felicia W. Sun et al.
JOURNAL OF NEUROSCIENCE (2016)
Novel PAMs Targeting NMDAR GluN2A Subunit
Zixiu Xiang et al.
NEURON (2016)
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
David H. Hackos et al.
NEURON (2016)
Memantine, an NMDA receptor antagonist, improves working memory deficits in DGKβ knockout mice
Kenichi Kakefuda et al.
NEUROSCIENCE LETTERS (2016)
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit
Robert A. Volkmann et al.
PLOS ONE (2016)
Forgetting of long-term memory requires activation of NMDA receptors, L-type voltage-dependent Ca2+ channels, and calcineurin
Ricardo Marcelo Sachser et al.
SCIENTIFIC REPORTS (2016)
Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
Phil Skolnick et al.
ACTA NEUROPSYCHIATRICA (2015)
Context-Dependent GluN2B-Selective Inhibitors of NMDA Receptor Function Are Neuroprotective with Minimal Side Effects
Hongjie Yuan et al.
NEURON (2015)
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman et al.
NEUROSCIENCE LETTERS (2015)
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients
Manuela Mellone et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions
Anders Bach et al.
SCIENTIFIC REPORTS (2015)
Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
Phil Skolnick et al.
ACTA NEUROPSYCHIATRICA (2015)
NMDA Receptor Function During Senescence: Implication on Cognitive Performance
Ashok Kumar
FRONTIERS IN NEUROSCIENCE (2015)
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Nicolas D. Iadarola et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Prosurvival NMDA 2A Receptor Signaling Mediates Postconditioning Neuroprotection in the Hippocampus
Xi Zhang et al.
HIPPOCAMPUS (2015)
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
Marja D. Sepers et al.
DRUG DISCOVERY TODAY (2014)
Distinct Functional and Pharmacological Properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA Receptors
Kasper B. Hansen et al.
NEURON (2014)
GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity
Olivia A. Shipton et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Organization, control and function of extrasynaptic NMDA receptors
Thomas Papouin et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
Synaptic Dysfunction in the Hippocampus Accompanies Learning and Memory Deficits in Human Immunodeficiency Virus Type-1 Tat Transgenic Mice
Sylvia Fitting et al.
BIOLOGICAL PSYCHIATRY (2013)
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares et al.
Current Alzheimer Research (2013)
Triheteromeric NMDA Receptors at Hippocampal Synapses
Kenneth R. Tovar et al.
JOURNAL OF NEUROSCIENCE (2013)
Influence of GluN2 subunit identity on NMDA receptor function
D. J. A. Wyllie et al.
NEUROPHARMACOLOGY (2013)
The NMDA receptor as a target for cognitive enhancement
Graham L. Collingridge et al.
NEUROPHARMACOLOGY (2013)
Diversity in NMDA Receptor Composition: Many Regulators, Many Consequences
Antonio Sanz-Clemente et al.
NEUROSCIENTIST (2013)
Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Ning Bai et al.
MOLECULAR BRAIN (2013)
NMDA Receptor Antagonists for Treatment of Depression
Zeynep Ates-Alagoz et al.
PHARMACEUTICALS (2013)
Interactions between NMDA and dopamine receptors: A potential therapeutic target
Min Wang et al.
BRAIN RESEARCH (2012)
Regulation of NMDA receptors by the tyrosine kinase Fyn
Catherine H. Trepanier et al.
FEBS JOURNAL (2012)
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Lobna Ibrahim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Ifenprodil reduces excitatory synaptic transmission by blocking presynaptic P/Q type calcium channels
Andrew J. Delaney et al.
JOURNAL OF NEUROPHYSIOLOGY (2012)
Subunit-Selective Allosteric Inhibition of Glycine Binding to NMDA Receptors
Kasper B. Hansen et al.
JOURNAL OF NEUROSCIENCE (2012)
NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear
Gemma L. Dalton et al.
NEUROPHARMACOLOGY (2012)
Distribution of Extrasynaptic NMDA Receptors on Neurons
Ronald S. Petralia
SCIENTIFIC WORLD JOURNAL (2012)
NMDA-complexes linked to spatial memory performance in the Barnes maze in CD1 mice
Maryam Ghafari et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines
Laetitia Mony et al.
EMBO JOURNAL (2011)
Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function
Clare M. Gladding et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
Erkan Karakas et al.
NATURE (2011)
mGluR5 and NMDA Receptors Drive the Experience- and Activity-Dependent NMDA Receptor NR2B to NR2A Subunit Switch
Jose A. Matta et al.
NEURON (2011)
Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion In Vivo
John A. Gray et al.
NEURON (2011)
Synapses, NMDA receptor activity and neuronal A beta production in Alzheimer's disease
Karim Bordji et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats
Brigitte Potier et al.
AGING CELL (2010)
Memantine Improves Cognition and Reduces Alzheimer's-Like Neuropathology in Transgenic Mice
Hilda Martinez-Coria et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
Gislaine Z. Reus et al.
BRAIN RESEARCH BULLETIN (2010)
NEU2000, AN NR2B-SELECTIVE, MODERATE NMDA RECEPTOR ANTAGONIST AND POTENT SPIN TRAPPING MOLECULE FOR STROKE
Sung Ig Cho et al.
DRUG NEWS & PERSPECTIVES (2010)
Identification and Characterization of Novel NMDA Receptor Antagonists Selective for NR2A-over NR2B-Containing Receptors
Ezio Bettini et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
Sabine Endele et al.
NATURE GENETICS (2010)
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential
Laetitia Mony et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
Beata Karolewicz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression
Fabrizio Gardoni et al.
JOURNAL OF NEUROSCIENCE (2009)
Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
Alban Latremoliere et al.
JOURNAL OF PAIN (2009)
Ionotropic Glutamate Receptors in Spinal Nociceptive Processing
Max Larsson
MOLECULAR NEUROBIOLOGY (2009)
THE EFFECTS OF AGING ON N-METHYL-D-ASPARTATE RECEPTOR SUBUNITS IN THE SYNAPTIC MEMBRANE AND RELATIONSHIPS TO LONG-TERM SPATIAL MEMORY
X. Zhao et al.
NEUROSCIENCE (2009)
Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
Ruslan I. Stanika et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Negative regulation of neurogenesis and spatial memory by NR2B-containing NMDA receptors
Mei Hu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test
David L. Walker et al.
LEARNING & MEMORY (2008)
Effects of a NR2B Selective NMDA Glutamate Antagonist, CP-101,606, on Dyskinesia and Parkinsonism
John G. Nutt et al.
MOVEMENT DISORDERS (2008)
LTP promotes a selective long-term stabilization and clustering of dendritic spines
Mathias De Roo et al.
PLOS BIOLOGY (2008)
Memantine:: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system -: too little activation is bad, too much is even worse
Chris G. Parsons et al.
NEUROPHARMACOLOGY (2007)
Extrasynaptic and synaptic and uniform pools in rat hi NMDA receptors form stable ppocampal slices
Alexander Z. Harris et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity
Makoto Kawai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites
Makoto Kawai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-l-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone -: A potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain
Makoto Kawai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus
Rana A. Al-Hallaq et al.
JOURNAL OF NEUROSCIENCE (2007)
The NMDA receptor/ion channel complex: A drug target for modulating synaptic plasticity and excitotoxicity
Benedict C. Albensi
CURRENT PHARMACEUTICAL DESIGN (2007)
NMDA receptor surface mobility depends on NR2A-2B subunits
Laurent Groc et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane
Phillip R. Zoladz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
The chemical biology of clinically tolerated NMDA receptor antagonists
Huei-Sheng Vincent Chen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The NMDA receptor NR2B subunit: A valid therapeutic target for multiple CNS pathologies
PL Chazot
CURRENT MEDICINAL CHEMISTRY (2004)
NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats
RH Wessell et al.
NEUROPHARMACOLOGY (2004)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102
IA Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
GE Hardingham et al.
NATURE NEUROSCIENCE (2002)
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies
GC Palmer
CURRENT DRUG TARGETS (2001)
NMDA receptor subunits: diversity, development and disease
S Cull-Candy et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
JE Nash et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
